Eric S Calhoun - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Eric S Calhoun

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

The American Journal of Pathology|September 26, 2003

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targetsEric S Calhoun, Jessa B Jones, Raheela Ashfaq, et al.

Human Mutation|August 31, 2006

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancersLaura D Wood, Eric S Calhoun, Natalie Silliman, et al.

Nature|July 8, 2011

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisGina M DeNicola, Florian A Karreth, Timothy J Humpton, et al.

Science (New York, N.Y.)|September 6, 2008

Core signaling pathways in human pancreatic cancers revealed by global genomic analysesSiân Jones, Xiaosong Zhang, D Williams Parsons, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

The American Journal of Pathology|September 26, 2003

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targetsEric S Calhoun, Jessa B Jones, Raheela Ashfaq, et al.

Human Mutation|August 31, 2006

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancersLaura D Wood, Eric S Calhoun, Natalie Silliman, et al.

Nature|July 8, 2011

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisGina M DeNicola, Florian A Karreth, Timothy J Humpton, et al.

Science (New York, N.Y.)|September 6, 2008

Core signaling pathways in human pancreatic cancers revealed by global genomic analysesSiân Jones, Xiaosong Zhang, D Williams Parsons, et al.

Pageof 2